A B S T R A C T Prostaglandin synthesis and T lymphocyte colony formation have been examined in previously untreated patients with Hodgkin's disease. Mononuclear cells have been isolated from peripheral blood and spleens of these patients. Significant augmentation in prostaglandin E levels were noted in the mononuclear cell cultures from Hodgkin's disease patients compared with controls (1.64+0.29 vs. 0.39+0.09 ng/106 cells, P < 0.005). Measured prostaglandin E levels increased with advancing stage of disease. Virtually all of the prostaglandins were synthesized by the adherent monocyte cell population. Prostaglandin E was the major product. Clonal expansion of a T lymphocyte precursor cell, which gives rise to colonies >50 cells, was determined by a layered soft agar method. T colony formation was significantly reduced in patients with stage II, III, and IV disease. There were progressively reduced colony numbers seen with advancing stage of disease (609±209, 416+ 158, 207+58 compared with normals 2,274+360 colonies/106 cells plated; P < 0.005). The addition of inhibitors of endogenous prostaglandin synthesis resulted in significant augmentation of T colony number. However, a consistent relative decrease in T colony number was seen even when endogenous prostaglandin E synthesis was blocked. It would appear that both the prostaglandin-dependent and independent T colony precursor cells are lost with progressive stage of disease. A causative role of augmented prostaglandin synthesis in this stagedependent reduction of T colony formation could not be established.
INTRODUCTION
Impaired cell-mediated immunity is a well-reported occurrence in patients with Hodgkin's disease (1) (2) (3) (4) (5) (6) . Several of the in vitro assays used to assess mature T lymphocyte function in Hodgkin's disease have been shown to be inhibited by prostaglandins of the E series (7, 8) . Marked elevation of prostaglandin E (PGE)l levels have been measured in immune cell cultures of patients with Hodgkin's disease (9) . The addition of a prostaglandin synthetase inhibitor to lectin-activated lymphocyte cultures augmented thymidine incorporation to control levels (9) . Monocytes have been shown to be the prime immune cell producers of prostaglandins (10, 11) and have also been identified as suppressors of T cell function in Hodgkins' disease (6, 9, 12) . It seems plausible to assume that monocytes may mediate immune cell suppression in part through their synthesis of prostaglandins; however, the mechanism(s) by which monocytes affect the profound and progressive immunosuppression seen in Hodgkin's disease has yet to be elucidated.
Recently, we have demonstrated that the clonal expansion of a circulating precursor T lymphocyte could be inhibited by synthetic PGE (13) . Further, it could be shown that monocyte derived PGE was an endogenous regulator of the proliferation and differentiation of this circulating precursor T cell (13) . Because 1977 and 1979 . None ofthe patients had received any prior radiation or chemotherapy. All subjects were studied during the initial phase of their diagnostic evaluation for extent of disease. Staging of disease followed the recommendations of the Ann Arbor Conference (14) ; histological classification was in accord with the recommendations made at the Rye Conference (15) . None of the patients had received medication that might interfere with any of the studies performed for at least 48 h before evaluation.
Mononuclear cell preparation. Mononuclear cells from peripheral blood drawn into sterile heparinized tubes were isolated by Ficoll-Hypaque density centrifugation (16 PGE levels measured at the initiation of monocyte cell culture were derived from release after burst synthesis by contaminating platelets or during monocyte adherence. To correct for PGE initially present when comparing basal synthetic rates of cultures, "de novo synthesis" was determined by measuring the difference between paired cultures with and without 1-2 ,uM indomethacin. In virtually every case measured there was >90% inhibition of prostaglandin synthesis when indomethacin or flurbiprofen were added to the cultures. T colony formation. T colony formation was evaluated in 36 patients with Hodgkin's disease. Marked reduction in colony number was evident in all stages of disease in peripheral blood as well as in the spleen preparations when compared with blood mononuclear cells from normals or lymph node cells derived from mastectomy patients (Table II) . The addition of indomethacin (2 ,uM) caused a significant (as determined by paired t test) increase in measured colony formation in the Hodgkin's disease specimens, but caused no significant augmentation in the comparable normal peripheral blood cells or mastectomy-derived lymph node cells. The data examined for individual patients showed that the addition of indomethacin resulted in a significant increase in colony number in 23 of 36 patients. As was previously reported (13), the addition of indomethacin caused significant augmentation of colony number in only 3 of the 13 normal subjects, but overall, colony formation for the 13 normal subjects was not significantly increased by the addition of indomethacin (13) . With the lymph node cells derived from patients undergoing mastectomy, 4 of 28 showed a significant increase in T colony number when indomethacin was added. Three of four of the latter patients had metastatic involvement of lymph nodes; 12 of the 28 patients had tumor metastatic to axillary lymph nodes. No significant augmentation of colony formation was seen when the data from the 28 mastectomy subjects were compared by the paired t test or the t test of means. Therefore, the effect of a prostaglandin synthetase inhibitor in peripheral blood and spleen-derived mononuclear cells of Hodgkin's disease patients differs from the peripheral blood cells of normal subjects and the lymph node cells of patients with breast cancer. The numbers of T colonies formed in patients with Hodgkin's disease appeared to be related to the stage of disease. With advancing stages of disease, fewer colonies were measured Fig. 1 . A significant negative correlation was noted in the absence and presence of indomethacin when T colony formation was plotted vs. stage of disease, Fig. 2 , and underscores the progressive loss of the precursor T cells that undergo clonal expansion to give colonies. It should also be noted that even in the presence of a prostaglandin synthetase inhibitor, progressive reduction of T colony number was observed. Furthermore, there was little change in the relative increase in colony formation seen for the various disease stages. This might suggest that there was concomitant loss of the prostaglandin "sensitive" as well as the prostaglandin "resistant" subpopulations of T precursor cells with advancing stages of disease.
The quantitative reduction in colony number did not appear to be correlated with a decrease in colony size or an increase in cell clusters containing <50 cells. Colony size for any given individual tended to be relatively uniform. The addition of indomethacin or flurbi- When mean colony numbers from patients with the nodular sclerosis classification were compared with colony formation by patients with the mixed cellularity classification, no significant difference was noted.
PGE levels. PGE levels were measured by radioimmunoassay in the cell-free supernate media from the various cell preparations. De novo (PGE level in culture-PGE in parallel culture with indomethacin) prostaglandin synthesis increased in a progressive fashion with advancing stage of disease for cells cul- tured in a standard fetal calf serum or cells cultured in autologous serum, Fig. 3 and Table IV . The correlation of measured PGE level with stage of disease was positive and significant for cells cultured with autologous serum, n = 27, r = 0.42, P < 0.05, Fig. 3 , but not significant for cells cultured in fetal calf serum, n = 31, r = 0.28. The difference in the mean levels of PGE measured in mononuclear cell-conditioned media from Hodgkin's patients compared with control subjects was significant whether fetal calf or autologous serum were used. When paired data for patient cells cultured in fetal calf serum or autologous serum were compared using the paired t test, significant differences were noted between stage II and III as well as the summarized data.
Fractionation of the mononuclear cells derived from the blood mononuclear cells of patients with Hodgkin's disease revealed that the adherent cells accounted for the increased prostaglandin synthesis, Table V. Paired data from 15 patients was compared, revealing that nonadherent cell synthesis of PGE did not differ significantly from controls. Adherent cell synthesis did differ significantly from the nonadherent cells. Furthermore, the cells cultured in the presence of serum (only fetal calf serum was tested) had higher measured levels of PGE than cells cultured in serumfree media. As with the T colony data, no significant difference was noted in PGE levels measured when the mononuclear cell cultures derived from patients with the nodular sclerosis histological classification were compared with cell cultures from patients with the mixed cellularity classification. A comparison of 40 paired samples from cultures supplemented with autologous serum showed that T colony number and PGE levels were significantly correlated (r = 0.43, P < 0.01). Similar analysis of the cell cultures in which fetal calf serum-supplemented media was used failed to demonstrate a significant correlation coefficient (r = 0.20) between T colony number and PGE level. The latter data is summarized graphically in Fig. 4 where, for the purposes Earlier studies have demonstrated that colonies of mature T lymphocytes can arise by clonal expansion from a circulating precursor cell (13, 20, 21) . The lymphocytes isolated from pooled colonies could be shown to have different functional activities (13) . Synthetic as well as monocyte-derived PGE inhibits this clonal proliferation (13) . Reports of elevated levels of PGE and suppressed mitogen response in mononuclear cells cultured from six patients with Hodgkin's disease suggested that prostaglandins may have contributed to the impaired immunity seen in such patients (9) . It is relevant to note that the disturbances in immune function that have been described in patients with Hodgkin's disease (1-6) involve several functional classes of T lymphocytes. Further, with progression of disease, immune cell depletion becomes more evident (6) . These latter features suggest that the pathophysiological mechanism leading to depressed immunocompetence in Hodgkin's disease may operate at the level of a precursor T lymphocyte.
When T colony formation was examined in our patients, significant depression of colony number was noted in the blood and spleen cell cultures as com- colony counts was seen when a potent inhibitor of prostaglandin synthetase was added to the cell culture. Monocyte-derived PGE levels were significantly elevated in Hodgkin's disease cell cultures compared with normals. The pattern of tritiated prostaglandins released by monocytes from Hodgkin's disease patients showed increased amounts of PGE2 when compared with monocytes from control subjects. The tritiated PGA2 we measured does not appear to be a primary cyclooxygenase product of monocytes (11, 22) and probably arises from the conversion of preformed PGE2 (23) . Conversion of PGE to PGA, which in our system ranged from 11-23%, may account for the variability in PGE levels measured by radioimmunoassay and in part account for the inability to significantly correlate levels with stage of disease. The balance between synthesis and conversion of PGE reveals the complexity of endogenous prostaglandin modulation of immune cell function. Greater levels of PGE and higher colony counts were mesured in cultures supplemented with autologous serum. These findings would appear to be in conflict.
Previously we have described that the proliferation and differentiation of the committed stem cell that gives rise to monocytes/macrophages can be regulated by agents with opposing actions (24) . The positive or promoting agent for the latter system is species specific and can overcome inhibition by PGE (24) . A parallel mechanism may exist for T cell precursors; in fact, a species-specific soluble agent(s) promoting T lymphocyte proliferation has been described (25) (26) (27) .
The presence of such an agent in the autologous serum could account for the relative refractoriness of precursor T cells to endogenous PGE levels.
Whereas there appeared to be a strong correlation between augmented monocyte synthesis of PGE and depressed T colony counts, this does not mean that depressed T colony formation was caused by the increased prostaglandin production. It was evident that blocking prostaglandin synthesis did not restore T colony numbers of the normal range in patients with stage II, III, or IV disease, Table II. In fact, what was observed was a consistent relative increase at each stage of disease when indomethacin was added. If increased prostaglandin synthesis was the direct cause of depressed T colony formation, then the addition of cyclooxygenase inhibitors should have resulted in greater augmentation of T colony formation with advancing stages of disease. The latter condition was not supported by the data obtained. Excluding those patients in whom the addition of indomethacin restored T colony formation to normal levels, it must be assumed that some other mechanism was involved in the depression of T colony counts seen in the patients with advanced stages of disease. Yet it is still possible to consider that persistent exposure to a suppressor substance such as prostaglandin may result in the continuous diminution of the precursor T cell pool.
In sum, the data showed a progressive loss of a precursor T cell with advancing stage of disease but did not identify the mechanism or mediator that caused this to occur. Whatever the pathophysiological mechanism, suppression and depletion at the level of the precursor cell probably plays an important role in the depressed immunocompetence seen in patients with Hodgkin's disease.
